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methoxyamine is chosen by the Rapid Access to Intervention Development (RAID) program of the National Cancer Institute as a potential new therapeutic
agent for further investigation [8].
To study the pharmacology and toxicology of
methoxyamine, an analytical method is desirable for
the measurement of methoxyamine in plasma samples. Since methoxyamine is a small organic amine,
it is very soluble in aqueous solution and plasma.
Moreover, methoxyamine possesses neither chromophore for spectrophotometric detection nor enough
mass sensitivity for mass spectrometric detection. It
imposes a great difficulty for plasma sample preparation and detection. Although, it had been reported
that methoxyamine could be detected by polarography [9], spectrophotometry [10], and HPLC–UV [11]
methods. Due to the lack of specificity, none of these
methods could be successfully applied to the measurement of methoxyamine in plasma. An extensive
literature search revealed no publication in the field.
This paper describes the development and validation of a tandem mass spectrometry method
for quantitative determination of methoxyamine in
plasma samples. Methoxyamine together with the
internal standard methoxyl-D3-amine was directly
derivatized in plasma sample with a novel chemical agent 4-(N,N-diethylamino)benzaldehyde. The
product solution was injected into an on-line column for analyte extraction. After the elution of
extractives, the derivatized analytes were quantitated by positive-electrospray-ionization tandem mass
spectrometry (ESI-MS-MS). The method developed
has been used to analyze methoxyamine in plasma
samples.

Experimental
Chemicals and solutions
Acetic acid, HPLC grade acetonitrile, 4-(N,N-diethylamino)benzaldehyde, formic acid, and trifluoroacetic acid were from Aldrich. Methoxyamine hydrochloride (CH3 ONH2 .HCl) was from Sigma.
Methoxyl-D3-amine hydrochloride (CD3 ONH2 .HCl,
lot no. G582P1) was from CDN Isotopes Inc.
(Pointe-Claire, Que., Canada) and used as the internal
standard (I.S.).

A stock solution (10.0 mg/ml) of methoxyamine
hydrochloride (CH3 ONH2 .HCl) and a stock solution
(10.0 mg/ml) of methoxyl-D3-amine hydrochloride
(CD3 ONH2 .HCl) were prepared by dissolving appropriate amount of each compound in a known volume
of deionized water obtained from a NANOpure system (Barnstead, Dubuque, IA, USA). A stock solution
(175 mg/ml) of 4-(N,N-diethylamino)benzaldehyde
was prepared by dissolving appropriate amount of the
compound in a known volume of aqueous solution
of acetic acid (H2 O:CH3 COOH, 1:1, v/v). The above
stock solutions were stored at 4 ◦ C when not in use.
A working solution (5.00 g/ml) of methoxyamine
(CH3 ONH2 ) was prepared by a two-step dilution
(1/100, 8.88/100) of the methoxyamine hydrochloride
stock solution with deionized water. A working solution (60.0 ng/ml) of methoxyl-D3-amine (CD3 ONH2 )
was prepared by a three-step dilution (1/100, 1/100,
1.038/10) of the methoxyl-D3-amine hydrochloride
stock solution with deionized water. A working solution (10.0 mg/ml) of 4-(N,N-diethylamino)benzaldehyde was prepared by direct dilution of the stock
solution with an aqueous solution of formic acid
(H2 O:HCOOH, 2:1, v/v).
Preparations of plasma calibrators
and controls
Pooled human plasma from voluntary blood donors
containing no detectable methoxyamine was obtained
from the Case Western Reserve University Hospital
and used as the blank plasma. Plasma methoxyamine
calibrators (1.00, 2.50, 5.00, 10.0, 25.0, 50.0, 125,
250, 500, 1000 ng/ml) were prepared by the serial dilution of 5.00 g/ml methoxyamine working solution
with the blank human plasma. Plasma controls (5.00,
50.0, 500 ng/ml) were prepared by the serial dilution
of 5.00 g/ml methoxylamine working solution with
the blank human plasma. All plasma samples were
placed on ice before the derivatization reaction, and
stored at −20 ◦ C when not in use.
Derivatization of plasma methoxyamine
The derivatization reaction between the plasma
methoxyamine and 4-(N,N-diethylamino)benzaldehyde took place in a 0.65 ml Costar® microcentrifuge
tube (cat. no. 3208) from Corning Incorporated
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(Corning, NY, USA). Fifty microliters of H2 O and
50.0 l 60.0 ng/ml CD3 ONH2 (internal standard)
were first added to 150 l plasma sample containing CH3 ONH2 . After mixing, 50.0 l 4-(N,N-diethylamino)benzaldehyde solution (10.0 mg/ml) was added
to the mixture. The mixture was then vortexed, heated
at 80 ◦ C for 1 h in a dry bath incubator (Fisher Scientific, Pittsburgh, PA, USA), and centrifuged for
5 min in a C-1200 mini centrifuge (National Labnet
Co., Woodbridge, NJ, USA) before subjected to the
instrumental analysis.
Recovery studies
To assess the recovery of plasma methoxylamine
under different sample storage times and temperatures,
100 ng/ml methoxyamine plasma sample was prepared
by the dilution of methoxyamine working solution
(5.00 g/ml) with the blank human plasma. Aliquots
of plasma sample (150 l each) were pipetted into
Costar® microcentrifuge tubes and kept at 24, 4, and
−20 ◦ C, respectively. At different time intervals, these
samples were processed and analyzed. The derivatization of plasma methoxyamine was carried out at 24 ◦ C
(i.e. room temperature) and 80 ◦ C.
To validate the analytical procedures, plasma
methoxyamine standards and aqueous methoxyamine
references (5.00, 50.0, 500 ng/ml) were prepared separately by the serial dilution of methoxyamine working
solution (5.00 g/ml) with the blank human plasma
and deionized water. After the derivatization reaction
at 80 ◦ C for 1 h, the samples were analyzed. The relative recovery of methoxyamine was determined by
comparing the mean-peak-area ratio of methoxyamine
to the internal standard in the plasma standards to the
mean-peak-area ratio of methoxyamine to the internal
standard in the aqueous references.
Pharmacokinetic study
Plasma methoxyamine elimination kinetics was
determined using male CD1 mice from the Jackson
Laboratory (Bar Harbor, ME, USA). The mice (four
mice per group) were randomly treated with single
bolus intraperitoneal injection of 2, 5 and 20 mg
methoxyamine hydrochloride (CH3 ONH2 .HCl)/kg
mouse. Blood samples were collected into heparinized
tubes at 1, 2.5, 5, 10, 20, 30, and 60 min after the

injection using a needle and syringe via an approach
to the heart under ether anesthesia. The blood samples were placed on ice and centrifuged within 2 h of
the collections. The resultant plasma samples were
stored at −20 ◦ C prior to the analysis. In this work,
the pooled mouse plasma from mice without the injection of methoxyamine hydrochloride was used as
the blank mouse plasma.
Instrumentation
The instrumentation system consisted of an HP1100
pump (Hewlett-Packard, Palo Alto, CA, USA), an
HP1100 autosampler, a stainless steel in-line filter
(0.5 m pore, 0.23 l dead volume, Upchurch Scientific, Oak Harbor, WA, USA), an Oasis® HLB extraction column (2.1 mm × 20 mm, Waters, Milford,
MA, USA), a Rheodyne 7000 two-position 6-port
switching valve (Supelco, Bellefonte, PA, USA), a
stainless steel splitting tee (1/16 in. × 0.25 mm, Valco,
Houston, TX, USA), and a Quattro II triple quadrupole mass spectrometer (Micromass, Manchester,
UK).
The fluidic connection of the system is shown in
Fig. 1. High-pressure polyether ether ketone (PEEK)
tubing (0.0625 in. o.d.) was used. Except the connection between the splitting tee and the MS detector
(0.005 in. i.d.), all other connections used 0.01 in. i.d.
tubing. At the position 1 of the switching valve, the
extraction solvent carried the plasma sample from
the autosampler to the extraction column where the
analytes were retained and the plasma matrix was
excluded to the waste. At the position 2 of the switching valve, the elution solution eluted the retained
compounds from the extraction column, and carried
them to the splitting tee where the flow was diverted
to the ESI-MS-MS detector and the waste with a
split ratio of 1:5. The smaller flow (ca. 100 l/min)
went to the MS detector and the larger one to the
waste.
On-line sample preparation
On-line extraction of methoxyamine and internal
standard from plasma were performed on an Oasis®
HLB extraction column. Prior to the analysis, the extraction column was first equilibrated with the extraction solvent (H2 O) at a flow rate of 2.0 ml/min for
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Fig. 1. The block diagram of the instrumentation system.

about 1.0 min with the switching valve on the position 1 (Fig. 1). During the analyses, 10 l derivatized
plasma sample was injected by the autosampler and
carried onto the extraction column by the extraction
solvent (H2 O) at a flow rate of 2.0 ml/min. The plasma
matrix was washed away by the extraction solvent to
the waste, and the analytes of interest were extracted
by the column. At 1 min after the sample injection,
the switching valve was turned to the position 2. Simultaneously, the extraction solvent was switched to
the elution solution (95% acetonitrile + 5% H2 O) at
a flow rate of 0.6 ml/min, which initiated the elution
of analytes from the extraction column. At 3 min after the elution, the switching valve was turned back to
the position 1. The column was continuously washed
with the elution solution at a flow rate of 2.0 ml/min
for another 0.5 min. Finally, the extraction column
was equilibrated with the extraction solvent at a flow
rate of 2.0 ml/min for 0.5 min before the next sample
injection. The total run time was about 5.0 min per
sample.
Mass spectrometric detection
The Quattro II triple quadrupole mass spectrometer
was operated under the positive-electrospray-ionization
mode (ESI+). It was tuned by infusion of a reaction
mixture of methoxyamine and methoxyl-D3-amine
(1.25 g/ml each) with 4-(N,N-diethylamino)benzaldehyde (2.5 mg/ml) in 50% acetonitrile + 40%
H2 O + 10% formic acid (which was needed for the
derivatization reaction) at a flow rate of 3 l/min
with a syringe pump (Harvard Apparatus, South Natick, MA, USA). The optimized ionization conditions
were: nitrogen sheath and desolvation gas at 10 and

350 l/h, capillary at 3.5 kV, HV lens at 0.5 kV, cone at
34 V, skimmer at 1.5 V, RF lens at 0.2 V, ion source
temperature at 70 ◦ C, ion energy at 1.2 V, low- and
high-mass resolution at 15, and mutliplier at 650 V.
Full-scan spectra were acquired in the continuum
mode at a scan rate 500 amu/s.
Multiple reaction monitoring (MRM) data were
acquired with the following parameters: m/z 207 >
149 for the derivatization product of methoxylamine, m/z 210 > 149 for the derivatization product of methoxyl-D3-amine, argon collision gas at
2.0–2.5 bar, cone at 34 V, collision energy at 20 V for
each analyte, low- and high-mass resolution at 15 for
both quadrupole 1 and 3, dwell time at 0.3 s, and the
inter-scan delay at 0.03 s. The ionization parameters
were the same as those described previously.
Data analysis
Data acquisition and peak integration were done
with Micromass Masslynx software (Version 3.4). The
peak-area ratios of the derivatized methoxyamine to
the derivatized internal standard were plotted against
the methoxyamine concentration for the regression
equation. The plasma methoxyamine concentrations
of the unknown samples were determined by the regression equation after obtaining the peak-area ratios
from their mass chromatograms.
Non-compartmental method was used to analyze
the data of pharmacokinetic study using WinNonLin
(Version 4.0.1) (Pharsight Corp., Mountain View, CA,
USA). The area under the curve (AUC) was determined by the linear trapezoidal rule, and the half-life
(T1/2 ) was estimated from the terminal portion of the
curve.
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Fig. 4. The mass spectra of the reactants and products of the derivatization reactions: (A) 1.25 g/ml methoxyamine and methoxyl-D3-amine
in 50% acetonitrile + 0.3% HCOOH; (B) 2.5 mg/ml 4-(N,N-diethylamino)benzaldehyde in 50% acetonitrile + 10% formic acid and (C) the
1:1 mixture of (A) and (B) at the room temperature.

(Fig. 4A), 4-(N,N-diethylamino)benzaldehyde at m/z
178 (Fig. 4B), and the products of the derivatization reactions at m/z 207 and 210 (Fig. 4C). The
positive ESI-MS-MS mode was used for both the
structure elucidation of the products of derivatization reactions by selecting parent ions at m/z 207
and 210 and monitoring their daughter ions over
the m/z ratio of 100–230 (Fig. 5), and the quantitative measurement of the derivatized analytes (m/z
207 > 149 for methoxyamine, and m/z 210 > 149
for methoxyl-D3-amine). Although many endogenous compounds in plasma samples coeluted with
the derivatized analytes, the quantitative analysis by
ESI-MS-MS showed no interference to the deriva-

tized analytes. Therefore, it required no analytical
separation column.
Structure elucidation
It was clearly identified in Fig. 4 that there were
two quasi-molecular ions at m/z 207 and 210 in the reaction mixture, which matched perfectly with the H+
adducts of the expected products of methoxyamine
(m/z 207) and methoxyl-D3-amine (m/z 210). Furthermore, the conversion efficiency of the derivatization
reaction could be revealed by the complete disappearance of the mass peaks of methoxyamine (m/z 48) and
methoxyl-D3-amine (m/z 51).
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Fig. 5. The mass spectra of fragments ions from the products of the derivatization reactions. The daughter ions of peaks (m/z 210 and
207) in Fig. 4C.

To elucidate the structures of the products of the
derivatization reactions, the fragmentation of the
product peaks (m/z 207 and 210) was carried out
by colliding with argon gas in the collision cell inside of the mass spectrometer. The mass spectra of
daughter ions (fragments of the derivatized analytes)
were acquired by the ESI-MS-MS (Fig. 5). By the
comparison of the daughter ions spectra of the two
reaction products, the assignments of the fragment
ions could be made. Fig. 6 shows the assignments
of five major fragments of the expected products,
methoxyiminato- 4- (N,N- diethylamino)benzaldehyde
and methoxyl-D3-iminato-4-(N,N-diethylamino)benzaldehyde.
On-line sample preparation
Plasma sample preparation is often considered
as the bottleneck in drug analyses. To increase the
sample throughput, a Waters Oasis® HLB extraction

column (2.1 mm × 20 mm) was used for on-line sample preparation. According to its manufacturer, the
column was packed with a macroporous copolymer
of divinylbenzene and N-vinylpyrrolidone, which has
dual retention capability to both polar and non-polar
compounds. This type of column had been proven
to be effective for plasma sample preparations in
our previous works [15,16]. In this work, it was
found that the products of derivatization reaction,
methoxyiminato- 4- (N,N -diethylamino)benzaldehyde
and methoxyl-D3-iminato-4-(N,N-diethylamino)benzaldehyde retained strongly on the extraction column,
whereas the plasma proteins showed no sign of retention when H2 O was used as the loading and washing
solvent. With the use of the in-line filter and the
after-use storage in 50% CH3 CN aqueous solution,
the numbers of extraction performed by each column
were greater than 300 times.
The effect of flow rate of the sample extraction step
on the recovery of analytes was investigated. The data
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rate (Fig. 7A). At the low flow rate, the peak height
was large at first. As the flow rate increased, the peak
height reached its maximum and declined dramatically (Fig. 7B). In this work, an elution flow rate of
0.6 ml/min was chosen for the analytical procedures,
which provided the optimum detection sensitivity
and adequate elution time. At this flow rate, the actual fluid entering the mass spectrometer was about
100 l/min after a 1:5 ratio of post-column splitting.
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Fig. 6. The assignments of five major fragments of the derivatized
analytes, methoxyiminato-4-(N,N-diethylamino)benzaldehyde and
methoxyl-D3-iminato-4-(N,N-diethylamino)benzaldehyde.

indicated there was no significant change in the analyte recovery in the flow rate range of 0.5–3.0 ml/min.
Upon the consideration of sample throughput and column pressure, a flow rate of 2.0 ml/min was chosen in
the analytical procedures for sample extraction.
The elution of the derivatized analytes was largely
affected by the composition of mobile phase. It was
found that acetonitrile was a better organic solvent
than methanol in the terms of peak shape, retention
time, and signal response. The higher the percentage
of acetonitrile, the shorter was the retention time of the
derivatized analytes. In this work, an optimized composition of 95% CH3 CN + 5% H2 O was used as the
elution solution. It was worth noting that the addition
of volatile acid (i.e. formic acid, acetic acid, or trifluoroacetic acid) at the concentration ranged 0.05–4% to
the elution solution could cause dramatic reduction of
the analyte retention time due to the weakened interaction between the protonated analyte and the packing material in the extraction column, and resulted in
variations on the analyte recovery.
The flow rate of elution affects the analyte concentration at the outlet of the extraction column. Since
ESI-MS is a concentration-dependent detector, the
flow rate of elution can affect peak shape and intensity in a mass chromatogram. It was found that the
peak width became narrower with the increase of flow

Methoxyl-D3-amine, a deuterated methoxyamine,
was used as the internal standard for the measurement of methoxyamine in plasma samples. Plasma
methoxyamine together with methoxyl-D3-amine
reacted with the derivatizing agent 4-(N,N-diethylamino)benzaldehyde. The products of the derivatization
reaction, methoxyiminato-4-(N,N-diethylamino)benzaldehyde and methoxyl-D3-iminato-4-(N,N-diethylamino)benzaldehyde were detected by ESI-MS-MS.
The quantitation of plasma methoxyamine was carried
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plasma spiked with 100 ng/ml methoxyamine.
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Fig. 8. The representative mass chromatograms of human plasma samples: (A) the pooled human plasma without I.S. methoxyl-D3-amine;
(B) the pooled human plasma with I.S.; (C) 1.00 ng/ml plasma methoxyamine calibrator with I.S. and (D) 10.0 ng/ml plasma methoxyamine
calibrator with I.S.

out by monitoring one of the major fragments of
methoxyiminato - 4 - (N,N- diethylamino)benzaldehyde
(m/z 207 > 149) together with that of methoxyl-D3-iminato-4-(N,N-diethylamino)benzaldehyde (m/z 210 >
149). The specificity of the analytical measurement
was shown in Fig. 8, which indicated no interference
from the plasma matrices.

to internal standard in the plasma standard to the
mean-peak-area ratio of methoxyamine to internal
standard in the aqueous reference multiplies 100%,
was examined. By triplicate measurements, the mean
relative recoveries were 90.1, 91.4 and 94.7% at three
methoxyamine levels (5.00, 50.0 and 500 ng/ml).
Precision and accuracy

Recovery
The relative recovery of the analytical method, defined as the mean-peak-area ratio of methoxyamine

The precision and accuracy of the method were
determined by analyzing the plasma methoxyamine
controls at three concentration levels (5.00, 50.0 and
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306

Linearity
The linearity of the ESI-MS-MS response for
methoxyamine in human plasma was established over
the concentration range of 1.00–1000 ng/ml with a
correlation coefficient of 0.9999. The mean calibration curve from three separate calibration curves made
over one month of time gave a mean calibration equation y = 0.0579x with a CV of 2.4% for the slope.

plotted. The results demonstrated that mouse plasma
samples collected without injection of methoxyamine
hydrochloride showed no sign of interference from
endogeneous compounds, whereas plasma samples
following injections of methoxyamine hydrochloride
gave clear identification of methoxyamine. Representative mass chromatograms of mouse plasma samples
were given in Fig. 9. The plasma methoxyamine
60
methoxyamine (ng/mL)

500 ng/ml). Five and three replicates of each concentration were assayed for intra- and inter-assay
precision. The precision of the measurement of
methoxyamine in human plasma was shown in
Table 1. The coefficient of variations (CVs) for both
intra- and inter-assay were less than 4% at the three
concentration levels. The accuracy, defined as the
measured value divided by the accepted value multiplies 100%, were 95.0, 90.1, and 96.3% at the three
concentration levels by triplicate measurements.
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The limit of detection (LOD) and the limit of quantification (LOQ) for the method were calculated as 3
and 10 times of signal-to-noise ratio (peak-to-peak).
Based on five replicate analyses of 1.00 ng/ml plasma
methoxyamine calibrator, the calculated LOD and
LOQ of the method were 0.150 and 0.500 ng/ml,
respectively.
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Table 1
The intra- and inter-assay precision of plasma methoxyamine
Plasma
methoxyamine
(ng/ml)

Intra-assay
precision
(CV%, n = 5)

Inter-assay
precision
(CV%, n = 3)

5.00
50.0
500

2.2
1.3
1.9

3.7
1.1
0.49

40

Time (min)
600

Methoxyamine (ng/mL)

The validated method was used to determine
plasma methoxyamine in mice with and without bolus
injections of methoxyamine hydrochloride. After the
frozen mouse plasma samples (−20 ◦ C) were thawed
to the room temperature, 150 l aliquots were used
for the analyses according to the procedures described
in Section 2, and the internal calibration curve was
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Fig. 10. The plasma methoxyamine concentration profiles in mice.
Dosages: (A) 2.00 mg methoxyamine hydrochloride/kg mouse; (B)
5.00 mg methoxyamine hydrochloride/kg mouse and (C) 20.0 mg
methoxyamine hydrochloride/kg mouse.
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Table 2
Pharmacokinetic parameters of methoxyamine

Tmax (min)
Cmax (ng/ml)
AUClast (min ng/ml)
T1/2 (min)

to analyze plasma samples from the pharmacokinetic
study in mice.

2 (mg/kg)

5 (mg/kg)

20 (mg/kg)

5.00
50.30
704.82
20.13

2.50
112.00
2210.00
18.54

5.00
562.00
9535.25
18.03

profiles from mice following single bolus intraperitoneal injections of 2, 5, and 20 mg methoxyamine
hydrochloride per kilogram of mouse were shown
in Fig. 10. The pharmacokinetic parameters of
methoxyamine were summarized in Table 2. The
results indicate the method developed may be used
to accurately determine methoxyamine in plasma
samples.

Conclusions
A ESI-MS-MS with on-line sample extraction
method for the quantitative determination of methoxyamine in human and mouse plasma has been developed and validated. Methoxyamine was accurately
determined in plasma through its reaction with 4-(N,Ndiethylamino)benzaldehyde under the acidic conditions. The reaction product was confirmed by
fragmentation experiments. The protein-bound methoxyamine was recovered by heating at 80 ◦ C for 1 h.
This method was rugged and specific. It has been used
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